FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
37,645,518
Share change
+937,917
Total reported value
$972,746,740
Put/Call ratio
41%
Price per share
$25.85
Number of holders
129
Value change
+$28,637,569
Number of buys
62
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q2 2018

As of 30 Jun 2018, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,645,518 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Capital World Investors, BlackRock Inc., Bank of New York Mellon Corp, MILLER VALUE PARTNERS, LLC, STATE STREET CORP, Rubric Capital Management LP, WELLS FARGO & COMPANY/MN, VANGUARD GROUP INC, and PICTET ASSET MANAGEMENT LTD. This page lists 129 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.